Peer Review reports
From: Lentinan enhances the antitumor effects of Delta-like 1 via neutrophils
| Original Submission | ||
|---|---|---|
| 2 Apr 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 11 May 2022 | Reviewed | Reviewer Report |
| 1 Jun 2022 | Reviewed | Reviewer Report - Ewa Jabłońska |
| 14 Jun 2022 | Author responded | Author comments - Songbing Qin |
| Resubmission - Version 3 | ||
| 14 Jun 2022 | Submitted | Manuscript version 3 |
| 16 Jun 2022 | Author responded | Author comments - Songbing Qin |
| Resubmission - Version 4 | ||
| 16 Jun 2022 | Submitted | Manuscript version 4 |
| 17 Jun 2022 | Author responded | Author comments - Songbing Qin |
| Resubmission - Version 5 | ||
| 17 Jun 2022 | Submitted | Manuscript version 5 |
| 7 Jul 2022 | Author responded | Author comments - Songbing Qin |
| Resubmission - Version 6 | ||
| 7 Jul 2022 | Submitted | Manuscript version 6 |
| 13 Jul 2022 | Author responded | Author comments - Songbing Qin |
| Resubmission - Version 7 | ||
| 13 Jul 2022 | Submitted | Manuscript version 7 |
| Publishing | ||
| 18 Aug 2022 | Editorially accepted | |
| 25 Aug 2022 | Article published | 10.1186/s12885-022-10011-w |
You can find further information about peer review here.